Drug Discovery World
Now entering its 18th year, DDW stands out as the only truly global publication dedicated to all facets of drug discovery and development. It has earned a reputation as an essential journal within the industry, respected by professionals in the field. DDW is well-known for featuring insights from some of the top experts in the industry, providing a platform for these thought leaders to discuss and stimulate conversations around the pressing challenges related to the technological, strategic, and business aspects of the pharmaceutical and biopharmaceutical sectors. The journal operates on the principle of "Turning Science into Business." The publication explores the latest advancements in science and technology while focusing on their commercial implications. It aims to assess whether these innovations can genuinely enhance the drug discovery and development process, ultimately lowering costs and reducing failure rates, all while accelerating the introduction of new and effective therapies to the market. What sets DDW apart is its ability to engage a worldwide audience, from laboratory professionals to corporate leaders, helping them grasp new technologies and strategies and understand their potential impact on their specific areas of business.
Outlet metrics
Global
#925299
United States
#610975
Science and Education/Biology
#1346
Articles
-
2 days ago |
ddw-online.com | Megan Thomas
DDW’s Megan Thomas attended Nebius’ inaugural AI Discovery Awards in Amsterdam, where top prizes of $100,000 in GPU credits were awarded to four companies pioneering AI breakthroughs in cancer prediction, protein targeting, transcriptomic mapping, and precision diagnostics.
-
2 days ago |
ddw-online.com | Megan Thomas
Both online and in the DDW quarterly magazine, DDW editors interview industry researchers to shine a spotlight on their work in a feature called Meet the Researcher. A question often included is: If you could make everyone read one book, article or academic paper, what would it be and why? Here, DDW’s Megan Thomas compiles a reading list featuring the books suggested by these researchers.
-
2 days ago |
ddw-online.com | Megan Thomas
France’s National Research Agency (ANR) and Defense Innovation Agency (AID) will finance the BUNYANTIVIR project to introduce a novel therapeutic approach for Bunyaviricetes’ class of human pathogenic viruses found in tropical and subtropical regions.
-
2 days ago |
ddw-online.com | Megan Thomas
The Longitude Prize on ALS is a new £7.5 million ($10.28 million) global challenge prize to incentivise and reward cutting edge AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral scleosis (ALS), the most common form of motor neuron disease (MND). Open for entries from 25 June 2025 until 3 December 2025, it will initially award 20 teams £100,000 each in early 2026, with one team going on to win £1 million at the end of the five-year prize.
-
3 days ago |
ddw-online.com | Diana Spencer
Register your interest for the DDW Turning Science into Business Symposium, which will take place at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK in the afternoon on 4 November 2025. The half day event boasts a stellar line up of speakers sharing their insight on the opportunity and expertise within the drug discovery and development market.
Drug Discovery World journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://ddw-online.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →